Cotton Introduces Bill to Eliminate National Security Risk Posed by CCP-Affiliated Drugs

FOR IMMEDIATE RELEASE Contact: Patrick McCann (202) 224-2353 April 16, 2026 Cotton Introduces Bill to Eliminate National Security Risk Posed by CCP-Affiliated Drugs Washington, DC — Senator Tom Cotton (R-Arkansas) today introduced legislation to eliminate the national security risk posed by Chinese Communist Party (CCP) influence over entities that sell pharmaceuticals products to the American public. The Securing America’s Drug Supply from Communist China Act directs the Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) to ensure that drugs in the U.S. supply chain are not made by companies affiliated with the CCP. “Relying on our chief adversary for life-saving medicine endangers Arkansans and threatens our national security. My bill would ensure our drugs aren’t produced by companies affiliated with the Chinese Communist Party,” said Senator Cotton . Text of the bill can be found here . The Securing America’s Drug Supply from Communist China Act would: Direct FDA, in coordination with the HHS Office of National Security (HHS ONS), to review future drug applications and previously approved drugs made by Chinese entities, or entities licensing a product owned by a Chinese entity, to ensure that the company does not have ties to the Chinese Communist Party. Enable the destruction of drug products if they are determined to have been produced by a company with ties to the CCP. Appropriate $5,000,000 to carry out this work. ###